Back to top

HCP Prices Senior Notes

Read MoreHide Full Article

HCP, Inc. (HCP - Free Report) , a real estate investment trust (REIT), recently announced that it has priced 3.15% senior unsecured notes worth $300 million. These notes are scheduled to mature in 2022 and were priced at 98.888% of their face value to generate 3.28%.The offering is expected to close on July 23, 2012.

The notes offering is expected to generate net proceeds of $293.7 million, which will be utilized to fund future acquisitions and for general corporate purposes.

During the first quarter of 2012, the company issued $450 million of 3.75% senior unsecured notes scheduled to mature in 2019. The net proceeds of approximately $444.0 million from the transaction were utilized to repay the debt under its revolving credit facility and for general corporate purposes.

HCP reported first quarter 2012 FFO (funds from operations) of $264.8 million or 64 cents per share, compared with $149.7 million or 40 cents per share in the year-earlier quarter. Funds from operations, a widely used metric to gauge the performance of REITs, is obtained after adding depreciation and amortization and other non-cash expenses to net income.

Headquartered in Long Beach, California, HCP is engaged in acquiring, developing, managing, selling and leasing a diverse portfolio of healthcare real estate related properties. The company also provides mortgage and other financing to healthcare providers.

HCP follows a conservative approach to financial management by actively managing its debt-to-equity levels and maintaining multiple sources of liquidity like the revolving credit facility, access to capital markets and secured debt providers, and divesture of assets. The financial flexibility enables the company to take advantage of potential investment opportunities that in turn bolsters top-line growth.

HCP currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. We are also maintaining our long-term Neutral recommendation on the stock. One of its competitors, Ventas Inc. (VTR - Free Report) , also has a Zacks #3 Rank.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

HCP, Inc. (HCP) - free report >>

Ventas, Inc. (VTR) - free report >>

More from Zacks Analyst Blog

You May Like